Frick E, Stickl H
Fortschr Med. 1976 Jun 10;94(17):1019-24.
Cytotoxic antibodies to myelin can be demonstrated by the method of 51Cr-release from chick erythrocytes coated with myelin basic protein. The cytotoxic antibody is inactivated by heating to 56 degrees C and needs complement in order to exert its action. The antibody was determined as IgM and IgG. It has relative specifity and shows cross-reaction with other basic proteins. The cytotoxic antibody was found in only 8% of healthy persons. Patients with multiple sclerosis were positive in 87% of the cases and in acute cases in 94%. In other neurological diseases cytotoxic antibody was present in 64%. The occurrence of cytotoxic antibody to myelin protein is not specific for a particular neurological disorder, especially not for multiple sclerosis. Cytotoxic antibodies arise as a secondary phenomenon, they are not the cause of the disease involved. They appear to be suitable, however, to determine, in association with cellular immunological reactions against myelin which may be regarded as the "primary" immunological processes, the demyelination process in the multiple sclerosis focus.
针对髓磷脂的细胞毒性抗体可以通过用髓磷脂碱性蛋白包被的鸡红细胞释放⁵¹Cr的方法来证实。细胞毒性抗体经56℃加热后失活,且发挥作用需要补体。该抗体被确定为IgM和IgG。它具有相对特异性,并与其他碱性蛋白发生交叉反应。仅8%的健康人检测到细胞毒性抗体。多发性硬化症患者87%呈阳性,急性病例中94%呈阳性。在其他神经系统疾病中,64%存在细胞毒性抗体。针对髓磷脂蛋白的细胞毒性抗体的出现并非特定神经系统疾病所特有,尤其不是多发性硬化症所特有。细胞毒性抗体作为一种继发现象出现,它们不是所涉及疾病的病因。然而,它们似乎适合与针对髓磷脂的细胞免疫反应(可被视为“主要”免疫过程)一起,来确定多发性硬化症病灶中的脱髓鞘过程。